[1]孙慧宇,李梅君.替加环素治疗成人急性白血病化疗后中性粒细胞缺乏伴发热疗效及对患者凝血功能、炎症因子的影响[J].陕西医学杂志,2021,50(11):1437-1440.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.029]
　SUN Huiyu,LI Meijun.Curative effect of tigecycline in treatment of neutrophil deficiency with fever after chemotherapy in adult acute leukemia and its effect on coagulation function and inflammatory factors in patients[J].,2021,50(11):1437-1440.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.029]
点击复制

替加环素治疗成人急性白血病化疗后中性粒细胞缺乏伴发热疗效及对患者凝血功能、炎症因子的影响
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
50
期数:
2021年11期
页码:
1437-1440
栏目:
药物与临床
出版日期:
2021-11-05

文章信息/Info

Title:
Curative effect of tigecycline in treatment of neutrophil deficiency with fever after chemotherapy in adult acute leukemia and its effect on coagulation function and inflammatory factors in patients
作者:
孙慧宇; 李梅君
(锦州医科大学附属第三医院,辽宁 锦州024000)
Author(s):
SUN Huiyu; LI Meijun
(The Third Affiliated Hospital of Jinzhou Medical University,Jinzhou 024000,China)
关键词:
替加环素;  急性白血病;  化疗;  中性粒细胞缺乏;  发热;  凝血功能
Keywords:
Tigecycline;  Acute leukemia;  Chemotherapy;  Neutropenia;  Fever;  Coagulation function
分类号:
R 733.71
DOI:
DOI:10.3969/j.issn.1000-7377.2021.11.029
文献标志码:
A
摘要:
目的:探讨替加环素对成人急性白血病化疗后中性粒细胞缺乏伴发热的疗效及对患者凝血功能与炎症因子的影响。方法:对79例急性白血病化疗后中性粒细胞缺乏并发热的成人患者进行研究,患者均为碳青霉烯类药物抗感染治疗无效者,继而使用替加环素治疗。记录替加环素治疗7 d的临床疗效、体温与中性粒细胞恢复时间、治疗前及治疗7 d时凝血功能指标[纤溶酶原激活抑制物-1(PAI-1)活性、D-二聚体(D-D)、血小板计数(PLT)、纤维蛋白原(FBG)、部分凝血酶原时间(APTT)、凝血酶原时间(PT)]、炎症因子水平[白细胞介素-6(IL-6)、C反应蛋白(CRP)],及治疗期间的相关不良反应情况。结果:临床疗效显效41例(51.90%),有效27例(34.18%),无效11例(13.92%),总有效率为86.08%(68/79); 体温恢复时间(5.20±1.60)d,中性粒细胞恢复时间(6.20±1.48)d; 治疗7 d时凝血功能指标FBG较治疗前更低(P<0.01),APTT与PT较治疗前更高(P<0.01),两组PAI-1、D-D与PLT对比差异无统计学意义(均P>0.05); 治疗7 d时炎症因子指标(IL-6、CRP)较治疗前更低(均P<0.01),中性粒细胞数目较治疗前更高(P<0.01),体温较治疗前更低(P<0.01)。在治疗期间出现恶心呕吐3例、头痛2例,皮疹与肝肾功能异常各1例,不良反应发生率为8.86%(7/79)。结论:成人急性白血病化疗后中性粒细胞缺乏并发热患者使用替加环素治疗效果显著,可以有效抑制炎症反应,促使疾病康复,但该药对于凝血功能具有一定的影响,临床应加强凝血功能指标监测,以便保障治疗的安全性。
Abstract:
Objective:To investigate the curative effect of tigecycline in the treatment of neutrophil deficiency with fever after chemotherapy in adult acute leukemia and its effect on coagulation function and inflammatory factors in patients.Methods:79 cases of acute leukemia patients with neutropenia and fever after chemotherapy were selected for the study.All patients were ineffective in anti infection treatment with carbapenems,and then treated with tigecycline.The clinical efficacy of tigecycline treatment for 7 days,body temperature and neutrophil recovery time after tigecycline treatment,coagulation function indexes [plasminogen activator inhibitor-1(PAI-1)activity,D-Dimer(D-D),platelet count(PLT),fibrinogen(FBG),partial prothrombin time(APTT),prothrombin time(PT)] and the levels of inflammatory factors [interleukin-6(IL-6),C-reactive protein(CRP)]before and after tigecycline treatment for 7 days,as well as the related adverse reactions during the treatment were recorded.Results:41 cases(51.90%)were markedly effective,27 cases(34.18%)were effective,11 cases(13.92%)were ineffective,and the total effective rate was 86.08%(68/79).The recovery time of body temperature was(5.20±1.60)d,neutrophil recovery time was(6.20±1.48)d.After 7 days of treatment,FBG was lower than that before treatment(P<0.01),APTT and PT were higher than those before treatment(all P<0.01),and there was no significant difference in PAI-1,D-D and PLT between the two groups(all P>0.05); the levels of inflammatory factors(IL-6,CRP)were lower than those before treatment(all P<0.01),the number of neutrophils was higher than that before treatment(P<0.01),and the body temperature was lower than that before treatment(P<0.01).During the treatment,there were 3 cases of nausea and vomiting,2 cases of headache,1 case of rash and 1 case of liver and kidney dysfunction,and the incidence of adverse reactions was 8.86%(7/79).Conclusion:Tigecycline is effective in the treatment of acute leukemia patients with neutropenia and fever after chemotherapy,which can effectively inhibit the inflammatory reaction and promote the recovery of the disease.However,tigecycline has a certain impact on the coagulation function,so it is necessary to strengthen the monitoring of coagulation function indexes in order to ensure the safety of treatment.

参考文献/References:

[1] 滕 志,雷 秦.去甲氧柔红霉素联合阿糖胞苷对急性髓系白血病患者生存质量及毒副作用的影响[J].陕西医学杂志,2019,48(4):521-523.
[2] 王雪梅,汤久慧,王茂生,等.参芪杀白汤为主联合化疗治疗急性白血病合并脾周围炎临床研究[J].陕西中医,2020,41(2):202-205.
[3] 高泓浩,姚子龙,李 艳,等.高剂量替加环素治疗碳青霉烯类治疗无效的急性白血病化疗后粒细胞缺乏伴发发热的有效性与安全性回顾研究[J].中国实验血液学杂志,2018,26(3):684-690.
[4] 张 畅,唐亦舒,成 倩,等.急性白血病患者革兰阳性菌血流感染的病原学及临床特征分析[J].中国抗生素杂志,2020,45(11):1176-1181.
[5] 中华医学会血液学分会,中国医师协会血液科医师分会.中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南(2020年版)[J].中华血液学杂志,2020,41(12):969-978.
[6] 陈 愉,崔俊昌,佘丹阳,等.抗菌药物超说明书用法专家共识[J].中华结核和呼吸杂志,2015,38(6):410-444.
[7] 于 婷,郑 立,袁 颖.索拉非尼联合小剂量阿糖胞苷治疗急性髓细胞白血病疗效及对患者干细胞NF-κB及FLT3蛋白表达影响[J].陕西医学杂志,2018,47(10):1352-1354.
[8] 韦杰敏,赖小璇,章忠明,等.急性白血病患者细菌性血流感染临床和病原学分析[J].中国实验血液学杂志,2019,27(6):1774-1778.
[9] Yu J,Chen Y,Fang J,et al.Successful treatment of disseminated fusariosis in a patient with acute lymphoblastic leukemia:A case report and literature review[J].Medicine(Baltimore),2019,98(26):16246.
[10] 顾闰夏,魏 辉,王 迎,等.抗感染疗程对急性髓系白血病患者巩固化疗期伴发革兰阴性菌血流感染转归的影响[J].中华血液学杂志,2018,39(6):471-475.
[11] 魏 同,毛夏丽,周 琪,等.急性白血病粒细胞缺乏症患者医院感染的临床特征及影响因素研究[J].临床血液学杂志,2020,33(9):634-639.
[12] 张鹏鹏,王丽娜,李 明,等.血液病粒细胞缺乏症患者医院感染病原菌的分布及药敏分析[J].中国实验血液学杂志,2020,28(3):989-995.
[13] 陈满强.重组人粒细胞刺激因子联合抗菌药物对急性白血病化疗后中性粒细胞缺乏合并感染患者血清炎症因子的影响研究[J].山西医药杂志,2019,48(16):1998-2000.
[14] 张晓波,谢 佳,王 浩,等.替加环素治疗化疗后粒细胞缺乏伴发热恶性血液病患者的疗效观察[J].现代肿瘤医学,2019,27(22):4044-4047.
[15] Pugliese N,Salvatore P,Iula DV,et al.Ultrasonography-driven combination antibiotic therapy with tigecycline significantly increases survival among patients with neutropenic enterocolitis following cytarabine-containing chemotherapy for the remission induction of acute myeloid leukemia[J].Cancer Med,2017,6(7):1500-1511.
[16] 杨天立,刘铁芳,王向东,等.418例替加环素临床应用合理性分析[J].中国临床药理学杂志,2020,36(18):2905-2907.
[17] Ghosh S,Chakraborty M,Samanta S,et al.Analysis of blood stream infections,antibiograms and clinical outcomes in haematological patients with febrile neutropenia:Data from a tertiary care haematology institute in India[J].Ann Hematol,2021,100(2):395-403.
[18] 徐银丽,祁 慧,江翊国,等.替加环素治疗对重症患者凝血功能的影响[J].中国药物应用与监测,2020,17(1):6-9.
[19] 方会慧,许元宝,孙旭群,等.替加环素治疗血液系统恶性肿瘤并发感染的疗效及其影响因素[J].中国感染控制杂志,2021,20(6):505-511.
[20] 秦 伟,蔡晓辉,陈梅玉,等.替加环素治疗老年血液病重症感染引起的凝血功能异常及其对血清炎症因子水平的影响[J].中国老年学杂志,2021,41(9):1863-1866.(收稿:2021-07-02)

更新日期/Last Update: 2021-11-05